Track Abbott Laboratories — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Abbott Laboratories ABL.F · Stock Open Abbott Laboratories in new tab

97.60 EUR
P/E
36.02
EPS
2.65
Yield
2.21%
P/B
3.77
ROE
10.58
Beta
0.58
Loading chart...
Key Metrics
P/E36.02
EPS2.65
Book Value25.34
Price to Book3.77
Debt/Equity63.21
% Insiders0.495%
Growth
Revenue Growth0.13%
Earnings Growth-0.48%
Estimates
Forward P/E20.48
Forward EPS4.66
Dividend
Dividend Yield2.21%
Annual dividends2.18 EUR
Ex-Div. DateJuly 15, 2026
Payout78.96%
5y avg Yield1.82%

DCF Valuation

Tweak assumptions to recompute fair value for Abbott Laboratories (ABL.F)
Currency: EUR
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Abbott Laboratories Logo Abbott Laboratories Analysis (ABL.F)

United States Health Care Official Website Stock

Is Abbott Laboratories a good investment? Abbott Laboratories (ABL.F) is currently trading at 97.60 EUR.

In terms of valuation, the stock trades at a P/E ratio of 36.02. This high multiple suggests investors have priced in significant future growth expectations.

For income investors, Abbott Laboratories pays a dividend yield of 2.21%. With a payout ratio of 79%, the dividend appears to be under pressure.

Investor FAQ

Does Abbott Laboratories pay a dividend?

Yes, it pays an annual dividend of 2.18 EUR (2.21% yield).

What asset class is Abbott Laboratories?

Abbott Laboratories is classified as a Stock. You can compare it against 12 other assets in the "Related Symbols" list on this page.

Company Profile

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also provides laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion serology testing; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; and drug and alcohol test. In addition, the company offers pediatric and adult nutritional products and infant formula; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices. The company was formerly known as Abbott Alkaloidal Company and changed its name to Abbott Laboratories in 1915. Abbott Laboratories was founded in 1888 and is based in Abbott Park, Illinois.

Exchange Ticker
NYQ (United States) ABT
SGO (Chile) ABTCL.SN
SGO (Chile) ABT.SN
GER (Germany) ABL.DE
MEX (Mexico) ABT.MX
FRA (Germany) ABL.F
VIE (Austria) ABT.VI
BUE (Argentina) ABT.BA
MIL (Italy) ABT.MI
SAO (Brazil) ABTT34.SA
STU (Germany) ABL.SG
EBS (Ireland) ABT.SW
Trades
Dividend Yield
2.21%
5y avg 1.82%
Annual Dividends
2.18EUR
Next Ex. Div Date
July 15, 2026
Payout Ratio
78.96%
Dividend History paid per year (EUR)
Historical Dividends
Year Total Dividends
2027
1.81 EUR
July 13, 2027 (estimated) 0.6028
April 13, 2027 (estimated) 0.6028
Jan. 11, 2027 (estimated) 0.6028
2026
2.19 EUR
Oct. 12, 2026 (estimated) 0.5645
July 15, 2026 0.5409
April 15, 2026 0.5409
Jan. 15, 2026 0.5409
2025
2.03 EUR
Oct. 15, 2025 0.5065
July 15, 2025 0.5065
April 15, 2025 0.5065
Jan. 15, 2025 0.5065
2024
1.89 EUR
Oct. 15, 2024 0.4722
July 15, 2024 0.4722
April 12, 2024 0.4722
Jan. 11, 2024 0.4722
2023
1.75 EUR
Oct. 12, 2023 0.4378
July 13, 2023 0.4378
April 13, 2023 0.4378
Jan. 12, 2023 0.4378
2022
1.61 EUR
Oct. 13, 2022 0.4035
July 14, 2022 0.4035
April 13, 2022 0.4035
Jan. 13, 2022 0.4035
2021
1.55 EUR
Oct. 14, 2021 0.3863
July 14, 2021 0.3863
April 14, 2021 0.3863
Jan. 14, 2021 0.3863
2020
1.24 EUR
Oct. 14, 2020 0.3091
July 14, 2020 0.3091
April 14, 2020 0.3091
Jan. 14, 2020 0.3091
2019
1.10 EUR
Oct. 11, 2019 0.2747
July 12, 2019 0.2747
April 12, 2019 0.2747
Jan. 14, 2019 0.2747
2018
0.96 EUR
Oct. 12, 2018 0.2404
July 12, 2018 0.2404
April 12, 2018 0.2404
Jan. 11, 2018 0.2404
2017
0.68 EUR
Oct. 12, 2017 0.2275
April 11, 2017 0.2275
Jan. 11, 2017 0.2275
2016
0.89 EUR
Oct. 12, 2016 0.2232
July 13, 2016 0.2232
April 13, 2016 0.2232
Jan. 13, 2016 0.2232
2015
0.82 EUR
Oct. 13, 2015 0.2060
July 13, 2015 0.2060
April 13, 2015 0.2060
Jan. 13, 2015 0.2060
2014
0.76 EUR
Oct. 10, 2014 0.1889
July 11, 2014 0.1889
April 11, 2014 0.1889
Jan. 13, 2014 0.1889
2013
0.48 EUR
Oct. 10, 2013 0.1202
July 11, 2013 0.1202
April 11, 2013 0.1202
Jan. 11, 2013 0.1202
2012
1.73 EUR
Oct. 11, 2012 0.4378
July 11, 2012 0.4378
April 11, 2012 0.4378
Jan. 11, 2012 0.4121
2011
1.61 EUR
Oct. 12, 2011 0.4121
July 13, 2011 0.4121
April 13, 2011 0.4121
Jan. 12, 2011 0.3777
2010
0.38 EUR
Oct. 13, 2010 0.3777
Upcoming Dividends
Name Payment Date Status Amount
Abbott Laboratories Jul 15, 2026 0.540855 EUR
Abbott Laboratories Apr 15, 2026 0.540855 EUR
Abbott Laboratories Jan 15, 2026 0.540855 EUR
Abbott Laboratories Oct 15, 2025 0.506515 EUR
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion